On-Demand Webinar

Exploring the Evolution of Data Transparency and Its Impact on Patient Outcomes

Join us as our expert guests explore the evolution of data transparency, the maturity and challenges of the movement today, and what’s in store for the future.

 

About the webinar

The clinical data transparency movement is well underway, and clinical researchers have realized significant advances in their work due to data sharing.

Whether your organization is already part of the data sharing world, or you’re considering joining the movement, you will gain invaluable insight from those tasked with its leadership.

This is in The Impact Series.

You can register to see previous webinars here:

Have a SAS profile? To complete this form automatically Sign In

 

All personal information will be handled in accordance with the SAS Privacy Statement.

 
  Yes, I would like to receive occasional emails from SAS and SAS business partners about their products and services. I understand I can withdraw my consent at any time by clicking the opt-out link in the emails.
 
 

About the Experts

Speaker 2

Bill Gibson, SAS

Gibson, a Principal Product Manager, is responsible for the portfolio of life sciences-specific solutions. He has represented SAS at CDISC for 10 years, and he is active within PhUSE and various industry working groups.

Speaker 2

Dave Handelsman, Program Manager, Project Data Sphere

Handelsman is a health care and life sciences expert with more than 25 years of industry, software, data and management experience. At Project Data Sphere, he is responsible for growing the number of patient lives available to support cancer research, building an interactive online community of researchers, and leading the overall activities associated with achieving Project Data Sphere's mission to accelerate the development of new treatments and cures for cancer.
 

Speaker 2

Patrick Homer, SAS

Homer is principal domain expert for developing SAS’ life science capabilities. His areas of expertise reside in prediction, optimization, forecasting, AI and business intelligence. Since 2008, he has overseen the developments of a broad portfolio of advanced analytic solutions for life sciences, and he was also responsible for developing strategies to support the global market expansion of clinical trial data transparency. Prior to joining SAS, Homer spent 20 years in commercial life sciences in a variety of roles.

Speaker 1

Scott Martin, Chair of the ClinicalDataStudyRequest.com Steering Committee

Martin has been a consultant to the global biopharmaceutical industry at KMR Group for more than 20 years, focusing on R&D analytics and benchmarking. His areas of expertise include clinical development performance, resource management, assessing efficiency and productivity in R&D, and implementing processes to enhance performance.
 

Speaker 1

Asba Tasneem, PhD, Data Sharing Lead at Duke Clinical Research Institute

Asba Tasneem is a Portfolio Manager of the Supporting Open Access for Research (SOAR) data sharing initiative at the Duke Clinical Research Institute at Duke University. Under SOAR, Duke has collaborations with SAS, Vivli, Bristol-Myers Squibb and the American Heart Association.

Tasneem is a subject matter expert on data sharing and data analytics platform and services and provides strategic guidance to faculty researchers and operational leadership. She brings more than 17 years of academic and operational experience.

Prior to joining Duke, Tasneem was a Bioinformatics Scientist at the National Library of Medicine and a consultant and subject matter expert at Booz Allen and Hamilton.